CRH Plc
ISIN
IE0001827041
Ticker
CRG
Sector
Sub-Industry
Country
Ireland
Year Founded
1970
ISIN
IE0001827041
Ticker
CRG
Sector
Sub-Industry
Country
Ireland
Year Founded
1970
CRH is the leading building materials business in the world, employing 71,000 people at 3,155 locations in 28 countries. CRH is the largest building materials business in both North America and Europe and we also have regional positions in Asia.
We manufacture and supply a diverse range of integrated building materials, products and innovative end-to-end solutions, which can be found throughout the built environment, from major public infrastructure projects to commercial buildings and residential homes.
A Fortune 500 company, CRH is a constituent member of the FTSE 100 index, the EURO STOXX 50 index, the ISEQ 20 and the Dow Jones Sustainability Index (DJSI) Europe. CRH’s American Depositary Shares are listed on the NYSE.
71,000
Worldwide
| Line item in (usd) | 01.01.2019 | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Assets | N/A | N/A | 44,944,000,000.00 | 44,670,000,000.00 | 45,188,000,000.00 |
| Noncurrent Assets | N/A | N/A | 29,967,000,000.00 | 30,626,000,000.00 | 30,387,000,000.00 |
| Property Plant And Equipment | N/A | N/A | 19,317,000,000.00 | 19,502,000,000.00 | 18,921,000,000.00 |
| Investment Accounted For Using Equity Method | N/A | N/A | 626,000,000.00 | 653,000,000.00 | 649,000,000.00 |
| Other Noncurrent Receivables | N/A | N/A | 325,000,000.00 | 239,000,000.00 | 164,000,000.00 |
| Deferred Tax Assets | N/A | N/A | 129,000,000.00 | 109,000,000.00 | 88,000,000.00 |
| Other Noncurrent Financial Assets | N/A | N/A | 13,000,000.00 | 12,000,000.00 | 14,000,000.00 |
| Noncurrent Recognised Assets Defined Benefit Plan | N/A | N/A | N/A | 166,000,000.00 | 261,000,000.00 |
| Noncurrent Derivative Financial Assets | N/A | N/A | 184,000,000.00 | 97,000,000.00 | 3,000,000.00 |
| Current Assets | N/A | N/A | 14,977,000,000.00 | 14,044,000,000.00 | 14,801,000,000.00 |
| Inventories | N/A | N/A | 3,117,000,000.00 | 3,611,000,000.00 | 4,194,000,000.00 |
| Trade And Other Current Receivables | N/A | N/A | 4,086,000,000.00 | 4,569,000,000.00 | 4,569,000,000.00 |
| Current Tax Assets Current | N/A | N/A | 36,000,000.00 | 42,000,000.00 | 63,000,000.00 |
| Cash and cash equivalents | 2,686,000,000.00 | 4,218,000,000.00 | 7,721,000,000.00 | 5,783,000,000.00 | 5,936,000,000.00 |
| Current Derivative Financial Assets | N/A | N/A | 17,000,000.00 | 39,000,000.00 | 39,000,000.00 |
| Equity And Liabilities | N/A | N/A | 44,944,000,000.00 | 44,670,000,000.00 | 45,188,000,000.00 |
| Equity | 18,952,000,000.00 | 19,635,000,000.00 | 20,348,000,000.00 | 20,914,000,000.00 | 22,337,000,000.00 |
| Issued Capital | N/A | N/A | 333,000,000.00 | 309,000,000.00 | 302,000,000.00 |
| Retained Earnings | N/A | N/A | 11,565,000,000.00 | 19,770,000,000.00 | 21,992,000,000.00 |
| Share Premium | N/A | N/A | 7,493,000,000.00 | N/A | N/A |
| Treasury Shares | N/A | N/A | 386,000,000.00 | 195,000,000.00 | 297,000,000.00 |
| Other Reserves | N/A | N/A | 444,000,000.00 | 445,000,000.00 | 380,000,000.00 |
| Equity Attributable To Owners Of Parent | N/A | N/A | 19,656,000,000.00 | 20,233,000,000.00 | 21,691,000,000.00 |
| Noncontrolling Interests | N/A | N/A | 692,000,000.00 | 681,000,000.00 | 646,000,000.00 |
| Liabilities | N/A | N/A | 24,596,000,000.00 | 23,756,000,000.00 | 22,851,000,000.00 |
| Noncurrent Liabilities | N/A | N/A | 17,131,000,000.00 | 16,175,000,000.00 | 13,962,000,000.00 |
| Other Longterm Provisions | N/A | N/A | 953,000,000.00 | 937,000,000.00 | 845,000,000.00 |
| Deferred Tax Liabilities | N/A | N/A | 2,613,000,000.00 | 2,734,000,000.00 | 2,868,000,000.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | N/A | 556,000,000.00 | 475,000,000.00 | 277,000,000.00 |
| Noncurrent Derivative Financial Liabilities | N/A | N/A | 1,000,000.00 | 0.00 | 77,000,000.00 |
| Longterm Borrowings | N/A | N/A | 10,958,000,000.00 | 9,938,000,000.00 | 8,145,000,000.00 |
| Current Liabilities | N/A | N/A | 7,465,000,000.00 | 7,581,000,000.00 | 8,889,000,000.00 |
| Other Shortterm Provisions | N/A | N/A | 489,000,000.00 | 479,000,000.00 | 513,000,000.00 |
| Trade And Other Current Payables | N/A | N/A | 4,792,000,000.00 | 5,692,000,000.00 | 5,872,000,000.00 |
| Current Tax Liabilities Current | N/A | N/A | 619,000,000.00 | 550,000,000.00 | 702,000,000.00 |
| Current Derivative Financial Liabilities | N/A | N/A | 12,000,000.00 | 14,000,000.00 | 51,000,000.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | N/A | 1,257,000,000.00 | 549,000,000.00 | 1,491,000,000.00 |
| Line item in (usd) | 01.01.2019/ 01.01.2020 |
01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|---|
| Revenue | 28,132,000,000.00 | 25,888,000,000.00 | 29,206,000,000.00 | 32,723,000,000.00 |
| Profit Loss From Operating Activities | 2,793,000,000.00 | 2,026,000,000.00 | 3,331,000,000.00 | 3,894,000,000.00 |
| Finance Income | 22,000,000.00 | 0.00 | 0.00 | 65,000,000.00 |
| Finance Costs | 387,000,000.00 | 438,000,000.00 | 357,000,000.00 | 401,000,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | 67,000,000.00 | -118,000,000.00 | 55,000,000.00 | 0.00 |
| Profit Loss Before Tax | 2,181,000,000.00 | 1,454,000,000.00 | 3,103,000,000.00 | 3,469,000,000.00 |
| Income Tax Expense Continuing Operations | 534,000,000.00 | 445,000,000.00 | 661,000,000.00 | 785,000,000.00 |
| Profit Loss From Continuing Operations | 1,647,000,000.00 | 1,009,000,000.00 | 2,442,000,000.00 | 2,684,000,000.00 |
| Profit Loss From Discontinued Operations | 91,000,000.00 | 156,000,000.00 | 179,000,000.00 | 1,190,000,000.00 |
| Profit (loss) | 1,738,000,000.00 | 1,165,000,000.00 | 2,621,000,000.00 | 3,874,000,000.00 |
| Line item in (usd) | 01.01.2019 | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|
| Profit (loss) | N/A | 1,738,000,000.00 | 1,165,000,000.00 | 2,621,000,000.00 | 3,874,000,000.00 |
| Adjustments For Income Tax Expense | N/A | N/A | 499,000,000.00 | 721,000,000.00 | 1,155,000,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | N/A | 9,000,000.00 | 673,000,000.00 | 0.00 | 0.00 |
| Adjustments For Sharebased Payments | N/A | 86,000,000.00 | 96,000,000.00 | 110,000,000.00 | 101,000,000.00 |
| Cash Flows From Used In Operations | N/A | 4,714,000,000.00 | 4,928,000,000.00 | 5,253,000,000.00 | 5,371,000,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 469,000,000.00 | 432,000,000.00 | 401,000,000.00 | 374,000,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 3,881,000,000.00 | 3,938,000,000.00 | 4,210,000,000.00 | 3,954,000,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 727,000,000.00 | 351,000,000.00 | 1,494,000,000.00 | 3,253,000,000.00 |
| Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | N/A | N/A | 0.00 | 0.00 | 11,000,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 1,374,000,000.00 | 996,000,000.00 | 1,554,000,000.00 | 1,523,000,000.00 |
| Interest Received Classified As Investing Activities | N/A | 22,000,000.00 | 0.00 | 0.00 | 65,000,000.00 |
| Cash Flows From Used In Investing Activities | N/A | 217,000,000.00 | -1,060,000,000.00 | -2,546,000,000.00 | -884,000,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | 954,000,000.00 | 249,000,000.00 | 896,000,000.00 | 1,178,000,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 106,000,000.00 | 6,427,000,000.00 | 0.00 | 38,000,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 640,000,000.00 | 4,943,000,000.00 | 1,183,000,000.00 | 364,000,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 356,000,000.00 | 258,000,000.00 | 264,000,000.00 | 249,000,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -2,546,000,000.00 | 287,000,000.00 | -3,305,000,000.00 | -2,686,000,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 1,552,000,000.00 | 3,165,000,000.00 | -1,641,000,000.00 | 384,000,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -20,000,000.00 | 338,000,000.00 | -297,000,000.00 | -231,000,000.00 |
| Cash and cash equivalents | 2,686,000,000.00 | 4,218,000,000.00 | 7,721,000,000.00 | 5,783,000,000.00 | 5,936,000,000.00 |
Please note that some sums might not add up.
IE0001827041
549300MIDJNNTH068E74
FTSE 100
ISEQ Overall Index
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.